186 related articles for article (PubMed ID: 3041357)
21. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
[TBL] [Abstract][Full Text] [Related]
22. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
[TBL] [Abstract][Full Text] [Related]
23. Matched unrelated bone marrow transplantation for combined immunodeficiency.
Dalal I; Reid B; Doyle J; Freedman M; Calderwood S; Saunders F; Roifman CM
Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
[TBL] [Abstract][Full Text] [Related]
24. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
25. Advances in the management of infectious complications after bone marrow transplantation.
Wingard JR
Bone Marrow Transplant; 1990 Dec; 6(6):371-83. PubMed ID: 2129021
[TBL] [Abstract][Full Text] [Related]
26. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
27. Infections in children undergoing allogeneic bone marrow transplantation in India.
George B; Mathews V; Viswabandya A; Srivastava A; Chandy M
Pediatr Transplant; 2006 Feb; 10(1):48-54. PubMed ID: 16499587
[TBL] [Abstract][Full Text] [Related]
28. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
[TBL] [Abstract][Full Text] [Related]
29. [Infectious complications in cardiac transplantation: Lausanne experience].
Menafoglio A; Cometta A; Berguer DG; Stumpe F; Sadeghi H; Genton CY; Kappenberger L; Goy JJ
Schweiz Med Wochenschr; 1994 Aug; 124(34):1479-88. PubMed ID: 7939514
[TBL] [Abstract][Full Text] [Related]
30. Complications and risks in hematopoietic stem cell transplant patients.
Smith LA; Wright-Kanuth MS
Clin Lab Sci; 2001; 14(2):118-24. PubMed ID: 15625985
[TBL] [Abstract][Full Text] [Related]
31. [Infectious complications of heart transplantation. A prospective study for the first 6 years of a transplantation program].
Bernabeu-Wittel M; Cañas García-Otero E; Herrero Romero M; Ordóñez Fernández A; Martínez Martínez A; Pérez Bernal J; Cisneros Herreros JM
Rev Clin Esp; 1999 Aug; 199(8):489-95. PubMed ID: 10522428
[TBL] [Abstract][Full Text] [Related]
32. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.
Sykes M; Sharabi Y; Sachs DH
Bone Marrow Transplant; 1988 Sep; 3(5):379-86. PubMed ID: 3056545
[TBL] [Abstract][Full Text] [Related]
33. Herpes virus infections: clinical manifestations and therapeutic strategies in immunocompromised patients.
Saral R; Burns WH; Prentice HG
Clin Haematol; 1984 Oct; 13(3):645-60. PubMed ID: 6094062
[TBL] [Abstract][Full Text] [Related]
34. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
35. [Prophylaxis and therapy of infections in allogenic bone marrow transplantation in patients with hematologic diseases].
Pejin D; Pecić J; Patić V; Popović S; Dreher-Doroski H; Milutinović M; Uzurov V; Lenert P; Spasojević J; Gebauer E
Med Pregl; 1992; 45(9-10):317-23. PubMed ID: 1344465
[TBL] [Abstract][Full Text] [Related]
36. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
Kalaycioglu ME; Bolwell BJ
Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
[TBL] [Abstract][Full Text] [Related]
37. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
[TBL] [Abstract][Full Text] [Related]
38. Prophylaxis of infection in bone marrow transplants.
Winston DJ; Ho WG; Gale RP; Champlin RE
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S15-23. PubMed ID: 3127217
[TBL] [Abstract][Full Text] [Related]
39. [Prevention of infection after bone marrow transplantation].
Schmeiser T
Fortschr Med; 1991 Feb; 109(6):155-7. PubMed ID: 1646147
[TBL] [Abstract][Full Text] [Related]
40. Diminishing morbidity and mortality of bone marrow transplantation.
Tutschka PJ
Vox Sang; 1986; 51 Suppl 2():87-94. PubMed ID: 3020798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
